Edition:
United Kingdom

Acer Therapeutics Inc (ACER.OQ)

ACER.OQ on NASDAQ Stock Exchange Capital Market

25.58USD
16 Nov 2018
Change (% chg)

$1.40 (+5.79%)
Prev Close
$24.18
Open
$24.13
Day's High
$25.75
Day's Low
$24.13
Volume
8,040
Avg. Vol
12,884
52-wk High
$34.10
52-wk Low
$11.45

Latest Key Developments (Source: Significant Developments)

Acer Therapeutics Q3 Loss Per Share $0.43
Friday, 9 Nov 2018 

Acer Therapeutics Inc ::ACER THERAPEUTICS REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE.Q3 LOSS PER SHARE $0.43.Q3 EARNINGS PER SHARE VIEW $-0.53 -- THOMSON REUTERS I/B/E/S.CASH AND CASH EQUIVALENTS WERE $46.2 MILLION AS OF SEPTEMBER 30, 2018, COMPARED TO $15.6 MILLION AS OF DECEMBER 31, 2017.ACER THERAPEUTICS - BELIEVE CASH POSITION WILL BE SUFFICIENT TO FUND CURRENT OPERATING, CAPITAL REQUIREMENTS INTO H1 2020.  Full Article

Acer Therapeutics Says Entered License Agreement For Development And Exploitation With Assistance Publique - Hôpitaux De Paris
Tuesday, 25 Sep 2018 

Sept 25 (Reuters) - Acer Therapeutics Inc ::ACER THERAPEUTICS - ON SEPT 19, ENTERED LICENSE AGREEMENT FOR DEVELOPMENT AND EXPLOITATION WITH ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS.ACER THERAPEUTICS-AGREEMENT TO ACQUIRE EXCLUSIVE WORLDWIDE INTELLECTUAL PROPERTY RIGHTS TO 3 PATENT APPLICATIONS RELATING TO CERTAIN USES OF CELIPROLOL.ACER THERAPEUTICS SAYS PURSUANT TO AGREEMENT, CO WILL REIMBURSE AP-HP FOR CERTAIN COSTS AND WILL PAY ANNUAL MAINTENANCE FEE PAYMENTS - SEC FILING.ACER THERAPEUTICS-UNDER AGREEMENT, CO WILL CONTROL AND PAY COSTS OF ONGOING PATENT PROSECUTION AND MAINTENANCE FOR LICENSED APPLICATIONS.  Full Article

Acer Therapeutics Announces Closing Of Underwritten Public Offering Of Common Stock
Thursday, 14 Dec 2017 

Acer Therapeutics Inc ::ACER THERAPEUTICS ANNOUNCES CLOSING OF UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK.  Full Article

Acer Therapeutics Announces Pricing Of Underwritten Public Offering Of Common Stock
Tuesday, 12 Dec 2017 

Dec 12 (Reuters) - Acer Therapeutics Inc ::ACER THERAPEUTICS ANNOUNCES PRICING OF UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK.ACER THERAPEUTICS INC - ANNOUNCED PRICING OF ITS UNDERWRITTEN PUBLIC OFFERING OF 916,667 SHARES OF COMMON STOCK AT $12.00/SHARE.  Full Article

Acer Therapeutics Announces Proposed Underwritten Public Offering Of Common Stock
Monday, 11 Dec 2017 

Dec 11 (Reuters) - Acer Therapeutics Inc ::ACER THERAPEUTICS ANNOUNCES PROPOSED UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK.ACER THERAPEUTICS INC - INTENDS TO USE NET PROCEEDS FROM OFFERING TO FUND RESEARCH AND DEVELOPMENT EFFORTS, TO SEEK REGULATORY APPROVAL FOR EDSIVO.ACER THERAPEUTICS INC - ALSO INTENDS TO USE NET PROCEEDS FROM OFFERING TO INVEST IN PRE-COMMERCIAL ACTIVITIES FOR EDSIVO, AMONG OTHERS.  Full Article

Acer Therapeutics Q3 loss per share $1.09
Monday, 13 Nov 2017 

Nov 13 (Reuters) - Acer Therapeutics Inc ::Acer Therapeutics reports third quarter 2017 financial results and provides corporate update.Q3 loss per share $1.09.  Full Article